Eli Lilly (LLY) stock is in focus as eczema therapy Ebglyss delivers long term disease control for up to four years. Read ...
Asianet Newsable on MSN
Struggling with skin allergies? Homeopathy might be the answer
The interest in homoeopathy for skin health is not only based on tradition. It reflects a growing understanding that skin ...
Eli Lilly said on Friday that its eczema drug showed durable results in a late-stage post-marketing study, such as relief from persistent itch for up to four years in patients with the skin ...
Learn to recognise chronic hives (urticaria), its symptoms, and how it differs from allergies for timely diagnosis and ...
A newly identified brain–immune connection suggests stress may directly amplify skin inflammation through targeted cellular ...
What causes it, how it looks on different skin tones, and an available biologic treatment option that can be used with or ...
Tangs Clinical TCM Highlights Why Chronic Eczema Can Persist for Decades SINGAPORE, March 25, 2026 /PRNewswire/ -- A recent ...
Company shares climbed by more than 20% on Phase 2 study results suggesting the therapy could provide sustained relief when ...
Apogee Therapeutics has published phase 2 eczema data that suggest its anti-IL-13 antibody is a threat to Eli Lilly, ...
For people with eczema, stress can trigger flare-ups and worsen their itchy rashes. But the link between stress and skin ...
Representatives from the National Eczema Association recently met with policymakers on Capitol Hill to discuss stalled step ...
This next in a series of quick quizzes in dermatology asks -what’s the cause of this itchy, vesicular rash on the hands?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results